pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    bleomycin sulfate
    Bleomycin Sulfate
    Cervical Cancer Northstar Rx LLC
  • Phase 2
    bleximenib besylate
    bleximenib besylate
    Refractory Acute Myeloid Leukemia$JNJ JOHNSON & JOHNSON
  • Phase 3
    bomedemstat tosylate
    bomedemstat tosylate
    Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)$MRK Merck & Co., Inc.
← prev
page 42 of 62
next →
Pain89
Neurology1
Marketed
bosutinib
Bosutinib
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Alembic Pharmaceuticals Inc
  • Phase 2
    botensilimab
    botensilimab
    Metastatic Colorectal Cancer$AGEN AGENUS INC
  • Phase 2
    brexucabtagene autoleucel
    Tecartus (brexucabtagene autoleucel)
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…$GILD GILEAD SCIENCES, INC.
  • Marketed
    brigatinib
    Alunbrig (brigatinib)
    Non-Small Cell Lung Cancer Takeda Pharmaceuticals USA Inc
  • Phase 2
    bulumtatug fuvedotin
    bulumtatug fuvedotin [INN]
    Esophageal Squamous Cell Carcinoma (ESCC) Mabwell Shanghai Bioscience Co Ltd
  • Marketed
    cabazitaxel
    Jevtana (cabazitaxel)
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Sanofi-Aventis US LLC
  • Phase 2
    cabiralizumab
    cabiralizumab [INN]
    Pigmented Villonodular Synovitis Bristol-Myers Squibb Co
  • pre_registration
    cabozantinib
    cabozantinib
    Hepatocellular Carcinoma Lotus Pharmaceutical Co Ltd
  • Phase 2
    cafelkibart
    cafelkibart [INN]
    Solid Tumor LaNova Medicines Ltd
  • Marketed
    calaspargase pegol
    Asparlas (calaspargase pegol)
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Servier Pharmaceuticals LLC
  • Phase 1
    calotatug ginistinag
    calotatug ginistinag [INN]
    Colorectal Cancer$DAWN Day One Biopharmaceuticals, Inc.
  • Phase 2
    camonsertib
    camonsertib
    Solid Tumor XenoTherapeutics Inc
  • Phase 2
    camupepimut
    camupepimut
    Colorectal Cancer$ELTX Elicio Therapeutics, Inc.
  • Preclinical
    candesartan
    candesartan
    Pancreatic Ductal Adenocarcinoma Hebrew University of Jerusalem
  • Phase 2
    canerpaturev
    canerpaturev
    Metastatic Melanoma Takara Bio Inc
  • Marketed
    capmatinib hydrochloride
    Tabrecta (capmatinib hydrochloride)
    Non-Small Cell Lung Cancer$NVS NOVARTIS AG
  • Marketed
    carfilzomib
    Kyprolis (carfilzomib)
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$AMGN AMGEN INC
  • Marketed
    carmustine
    Carmustine
    Astrocytoma STI Pharma LLC
  • Phase 2
    carotuximab
    carotuximab
    Metastatic Castration-Resistant Prostate Cancer (mCRPC)$KAPA Kairos Pharma, LTD.
  • Phase 2
    casdozokitug
    casdozokitug
    Hepatocellular Carcinoma$CHRS Coherus Oncology, Inc.
  • Phase 3
    catequentinib hydrochloride
    catequentinib hydrochloride
    Soft Tissue Sarcoma Advenchen Laboratories LLC
  • Phase 1
    cedazuridine + decitabine + tolinapant
    cedazuridine + decitabine + tolinapant [INN]
    T-Cell Lymphomas Otsuka Pharmaceutical Co Ltd
  • Phase 3
    cediranib maleate
    cediranib maleate
    Epithelial Ovarian Cancer$AZN ASTRAZENECA PLC
  • Phase 2
    cemacabtagene ansegedleucel
    cemacabtagene ansegedleucel
    Primary Mediastinal B-Cell Lymphoma$ALLO Allogene Therapeutics, Inc.
  • Phase 2
    cemsidomide
    cemsidomide
    Anaplastic Large Cell Lymphoma (ALCL)$CCCC C4 Therapeutics, Inc.
  • Preclinical
    cerium oxide
    Radiodermatitis BioCurity Pharmaceuticals Inc
  • Phase 2
    certepetide
    certepetide
    Bile Duct Cancer (Cholangiocarcinoma)$LSTA LISATA THERAPEUTICS, INC.